Zack Z. Ramilevich, M.D., Joins Marcus Neuroscience Institute as a General Neurologist
-
March 26, 2026
-
2 min
March 26, 2026
March 26, 2026
FDA De Novo authorization establishes a new device classification for lenses designed to reduce migraine-associated light sensitivity
September 15, 2026
The approval includes additional 300 mg iodine/mL and 350 mg iodine/mL vial presentations.
July 17, 2026